Dr. Reinier Hernandez and Dr. Victor Santoro Fernandes have been awarded WARF Accelerator Phase 1 funding to advance TrackTGL, a novel PET-based cell tracking technology developed in the Department of Medical Physics. The award supports a focused translational effort to standardize and validate the technology in partnership with industry collaborators, positioning it for deployment in cell therapy development programs. TrackTGL enables highly sensitive, quantitative in vivo tracking of therapeutic cells, helping bridge imaging science and emerging cell-based therapies. This project emerged from the Department of Medical Physics Entrepreneurial Fellowship and exemplifies a structured PI–Entrepreneurial Fellow partnership, with Dr. Hernandez leading the radiochemistry innovation and scientific direction, and Dr. Fernandes leading translational execution, commercialization strategy, and industry engagement.